BPC-157 / TB-500 — Peptide Blend Research Compound

Catalog ID: BPTB | CAS: BPC-157 (137525-51-0) / TB-500 (77591-33-4)

Blend Overview

The BPC-157 / TB-500 blend is a high-purity, research-grade peptide formulation designed for in vitro and in vivo experimentation.
This dual-peptide combination is used to study cytoskeletal dynamics, actin regulation, angiogenesis, and tissue remodeling processes within cellular research environments.
Not for human consumption or therapeutic application.

Molecular Characteristics

• BPC-157 — Synthetic pentadecapeptide derived from gastric protein BPC.
  • Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
  • Molecular Formula: C₆₂H₉₈N₁₆O₂₂
  • Molecular Weight: ≈ 1419 g/mol
• TB-500 — Synthetic fragment of Thymosin Beta-4 peptide chain.
  • Sequence: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Gly-Lys-Thr-Asp-Ser-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH
  • Molecular Formula: C₂₁₂H₃₅₀N₅₆O₇₈S
  • Molecular Weight: ≈ 4964 g/mol
• Purity: ≥ 98 % (HPLC verified)
• Formulation: Lyophilized powder blend

Physical Properties

• Appearance: White to off-white lyophilized powder
• Solubility: Sterile water or 0.6 % acetic acid (for laboratory use only)
• Container: Sterile sealed vial

Storage & Stability

• Unreconstituted: Store at −20 °C, protected from light and moisture.
• Reconstituted: Aliquot and store at −20 °C; avoid repeated freeze–thaw cycles.

Research Context

The BPC-157 / TB-500 blend is used in preclinical studies to explore cytoskeletal repair, angiogenic factor expression, and extracellular matrix signaling.
Both peptides have been characterized for their actin-binding, fibroblast-migration, and endothelial modulation properties in controlled model systems.
Research aims to deepen understanding of synergistic peptide signaling involved in structural and cellular restoration processes.